The National Law Journal named New York partner Jim Badke and San Francisco partner Vernon M. Winters to its 2020 “Plaintiffs’ Lawyers Trailblazers” list for their high-profile intellectual property litigation work. The annual supplement profiles lawyers who continue to make their mark in various aspects of legal work, blazing trails in consumer rights, wrongful death and many other types of complex matters.
Jim was profiled for spending more than 30 years of his career helping to establish litigation as a way to promote life sciences innovation by the enforcement of medical device and pharmaceutical patents. He was praised for successfully representing pharmaceutical and life sciences company Bayer against Baxalta for patent infringement of its recombinant factor VIII replacement therapy drug for hemophilia. This is one of the largest biotech patent verdicts globally and one of the 10 highest verdicts of any kind in the District of Delaware.
Vern was praised for his trial victory for the world’s largest freestanding biologics company, Amgen, in a case protecting patents to its biologic drug Enbrel®, the first FDA-approved fusion protein and one of the world’s best-selling therapeutic proteins. After the district court released its opinion, Amgen’s stock rose by more than US$5 billion in the first five minutes, and more than US$12.3 billion by the end of the next trading day. Measured in terms of economic benefit, that exceeds the largest patent damages award ever by a factor of nearly five.